A phase 3 clinical trial has found that the injectable prescription medication tirzepatide, in combination with intensive lifestyle intervention, resulted in an additional 21.1% weight...
from SciTechDaily https://ift.tt/Ris17O0
Revolutionary Obesity Treatment: Tirzepatide Shows Groundbreaking 21.1% Weight Loss
November 01, 2023
0
Tags